1. Home
  2. AVDL vs LENZ Comparison

AVDL vs LENZ Comparison

Compare AVDL & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • LENZ
  • Stock Information
  • Founded
  • AVDL 2015
  • LENZ 2019
  • Country
  • AVDL Ireland
  • LENZ United States
  • Employees
  • AVDL N/A
  • LENZ N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • LENZ Medicinal Chemicals and Botanical Products
  • Sector
  • AVDL Health Care
  • LENZ Health Care
  • Exchange
  • AVDL Nasdaq
  • LENZ Nasdaq
  • Market Cap
  • AVDL 1.5B
  • LENZ 1.2B
  • IPO Year
  • AVDL 1996
  • LENZ 2021
  • Fundamental
  • Price
  • AVDL $14.35
  • LENZ $46.63
  • Analyst Decision
  • AVDL Strong Buy
  • LENZ Strong Buy
  • Analyst Count
  • AVDL 8
  • LENZ 4
  • Target Price
  • AVDL $20.88
  • LENZ $49.75
  • AVG Volume (30 Days)
  • AVDL 1.3M
  • LENZ 421.8K
  • Earning Date
  • AVDL 11-11-2025
  • LENZ 11-05-2025
  • Dividend Yield
  • AVDL N/A
  • LENZ N/A
  • EPS Growth
  • AVDL N/A
  • LENZ N/A
  • EPS
  • AVDL N/A
  • LENZ N/A
  • Revenue
  • AVDL $221,075,000.00
  • LENZ $5,000,000.00
  • Revenue This Year
  • AVDL $64.56
  • LENZ N/A
  • Revenue Next Year
  • AVDL $30.60
  • LENZ $285.73
  • P/E Ratio
  • AVDL N/A
  • LENZ N/A
  • Revenue Growth
  • AVDL 132.35
  • LENZ N/A
  • 52 Week Low
  • AVDL $6.38
  • LENZ $16.54
  • 52 Week High
  • AVDL $16.66
  • LENZ $50.40
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 43.90
  • LENZ 62.49
  • Support Level
  • AVDL $14.85
  • LENZ $39.52
  • Resistance Level
  • AVDL $15.58
  • LENZ $50.19
  • Average True Range (ATR)
  • AVDL 0.48
  • LENZ 2.31
  • MACD
  • AVDL -0.26
  • LENZ 0.29
  • Stochastic Oscillator
  • AVDL 12.16
  • LENZ 66.54

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Share on Social Networks: